![Eric Easom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 7 M $ al 30/06/2026
Eric Easom is the founder of AN2 Therapeutics, Inc., founded in 2017, where the title held is Chairman, President & Chief Executive Officer since 2024.
Current jobs include Director at Resilient Biotics, Inc. since 2019 and Director at Chagas Disease Foundation since 2018.
Former jobs include Senior Director-Business Development & Marketing at InteKrin Therapeutics, Inc. from 2007 to 2009, Director at Infectious Disease Research Institute from 2013 to 2014, and Vice President-Neglected Diseases at Anacor Pharmaceuticals LLC from 2009 to 2017.
Education includes undergraduate studies at the University of Louisville and an MBA from Kelley School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AN2 THERAPEUTICS, INC. 3,77 % | 31/03/2026 | 1.357.825 ( 3,77 % ) | 7 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Director Ejecutivo | 01/11/2019 |
Chagas Disease Foundation | Director/Miembro de la Junta | 01/06/2018 |
Resilient Biotics, Inc.
 Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops microbiome-based therapeutics | Director/Miembro de la Junta | 01/02/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/06/2017 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Presidente | 01/01/2013 |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Ventas & Marketing | 01/01/2009 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for metabolic and immune disorders | Health Technology |
University of Louisville
 University of Louisville Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Commercial Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Resilient Biotics, Inc.
Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops microbiome-based therapeutics | Commercial Services |
AN2 Therapeutics, Inc.
 AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Chagas Disease Foundation |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
